Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Xandra Owens Breakefield, Ph.D.

Co-Author

This page shows the publications co-authored by Xandra Breakefield and Bakhos Tannous.
Connection Strength

4.253
  1. Tannous et al. Respond. Mol Ther. 2009 Aug; 17(8):1311-1312.
    View in: PubMed
    Score: 0.714
  2. Mutant sodium channel for tumor therapy. Mol Ther. 2009 May; 17(5):810-9.
    View in: PubMed
    Score: 0.417
  3. Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat Methods. 2006 May; 3(5):391-6.
    View in: PubMed
    Score: 0.342
  4. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther. 2005 Mar; 11(3):435-43.
    View in: PubMed
    Score: 0.316
  5. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Sci Adv. 2021 Jan; 7(2).
    View in: PubMed
    Score: 0.237
  6. Membrane-bound Gaussia luciferase as a tool to track shedding of membrane proteins from the surface of extracellular vesicles. Sci Rep. 2019 11 22; 9(1):17387.
    View in: PubMed
    Score: 0.219
  7. Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Mol Ther Methods Clin Dev. 2019 Dec 13; 15:18-26.
    View in: PubMed
    Score: 0.215
  8. Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles. Cell Rep. 2019 04 02; 27(1):255-268.e6.
    View in: PubMed
    Score: 0.210
  9. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat Commun. 2015 May 13; 6:7029.
    View in: PubMed
    Score: 0.160
  10. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014 Jan 28; 8(1):483-494.
    View in: PubMed
    Score: 0.146
  11. Noninvasive in vivo monitoring of extracellular vesicles. Methods Mol Biol. 2014; 1098:249-58.
    View in: PubMed
    Score: 0.146
  12. Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis. Gene Ther. 2012 Nov; 19(11):1121.
    View in: PubMed
    Score: 0.134
  13. Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis. Gene Ther. 2011 Dec; 18(12):1173-8.
    View in: PubMed
    Score: 0.124
  14. TorsinA participates in endoplasmic reticulum-associated degradation. Nat Commun. 2011 Jul 12; 2:393.
    View in: PubMed
    Score: 0.123
  15. Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter. Cancer Gene Ther. 2010 Apr; 17(4):266-74.
    View in: PubMed
    Score: 0.109
  16. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol. 2009 Nov; 29(21):5923-40.
    View in: PubMed
    Score: 0.108
  17. siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells. Hum Mol Genet. 2008 May 15; 17(10):1436-45.
    View in: PubMed
    Score: 0.097
  18. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods. 2008 Feb; 5(2):171-3.
    View in: PubMed
    Score: 0.096
  19. A highly sensitive assay for monitoring the secretory pathway and ER stress. PLoS One. 2007 Jun 27; 2(6):e571.
    View in: PubMed
    Score: 0.093
  20. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7271-6.
    View in: PubMed
    Score: 0.091
  21. Heparin affinity purification of extracellular vesicles. Sci Rep. 2015 May 19; 5:10266.
    View in: PubMed
    Score: 0.040
  22. Microvesicle-associated AAV vector as a novel gene delivery system. Mol Ther. 2012 May; 20(5):960-71.
    View in: PubMed
    Score: 0.032
  23. In vivo tomographic imaging of red-shifted fluorescent proteins. Biomed Opt Express. 2011 Mar 16; 2(4):887-900.
    View in: PubMed
    Score: 0.030
  24. Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2. PLoS One. 2011 Jan 28; 6(1):e16282.
    View in: PubMed
    Score: 0.030
  25. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell. 2008 Nov 04; 14(5):382-93.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.